The report shows strong growth in Asian markets, with India at 8.8% CAGR, followed by China (8.7%) and South Korea (8.6%).

The event organised by Informa Markets in India, will be one-stop destination for innovative, cost-effective solutions for ...

We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a ...

Onyx Biotec Ltd. (OBL), a pharmaceutical company specializing in sterile water for injections, is making its debut on the ...

Analyst Naz Rahman from Maxim Group reiterated a Buy rating on scPharmaceuticals (SCPH – Research Report) and keeping the price target at ...

The latest GDP figures come as a blow to Rachel Reeves, the chancellor, who said she was not "satisfied with the numbers".

Anupam Rasayan India reported 37.11% decline in consolidated net profit to Rs 30.62 crore on 25.04% fall in revenue from operations to Rs 293.96 crore in Q2 FY25 over Q2 FY24.

Blueprint Medicines' AYVAKIT leads its revenue growth, while its pipeline targets multiple cancers. Read why BPMC stock is a ...

Net revenues totaled $2.8 million, an increase of 7.1%, and $7.9 million, a decrease of 5.7%, respectively, for the three- and nine-month periods ended September 30, 2024, compared to $2.6 million and ...

Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...

With the US obesity rate hovering at around 40%, tens of millions of Americans could take GLP-1 drugs over the next few years ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...